Amgen (Mexico) Today
| AMGN Stock | MXN 4,450 6.50 0.15% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Amgen is trading at 4449.50 as of the 16th of April 2024; that is -0.15 percent decrease since the beginning of the trading day. The stock's open price was 4456.0. Amgen has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Amgen Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 17th of March 2024 and ending today, the 16th of April 2024. Click here to learn more.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. AMGEN INC operates under Drug Manufacturers - Major classification in Mexico and is traded on Mexico Stock Exchange. The company has 533.98 M outstanding shares. More on Amgen Inc
Moving against Amgen Stock
| 0.77 | ALPEKA | ALPEK SAB de Earnings Call This Week | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Amgen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Amgen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Amgen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Robert Bradway |
| Business Concentration | Drug Manufacturers - Major, Healthcare (View all Sectors) |
Amgen Inc (AMGN) is traded on Mexican Exchange in Mexico and employs 25,200 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 2.46 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Amgen's market, we take the total number of its shares issued and multiply it by Amgen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Amgen Inc operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 533.98 M outstanding shares.
Amgen Inc has accumulated about 26.3 B in cash with 9.72 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 43.12.
Check Amgen Probability Of Bankruptcy
Ownership AllocationAmgen holds a total of 533.98 Million outstanding shares. The majority of Amgen Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amgen Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amgen. Please pay attention to any change in the institutional holdings of Amgen Inc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Amgen Ownership Details
Amgen Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Amgen jumping above the current price in 90 days from now is under 95%. The Amgen Inc probability density function shows the probability of Amgen stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon Amgen has a beta of 0.4829. This suggests as returns on the market go up, Amgen average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Amgen Inc will be expected to be much smaller as well. Additionally, amgen Inc has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Amgen to move above the current price in 90 days from now is under 95 (This Amgen Inc probability density function shows the probability of Amgen Stock to fall within a particular range of prices over 90 days) .
Amgen Inc Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Amgen market risk premium is the additional return an investor will receive from holding Amgen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Amgen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Amgen's alpha and beta are two of the key measurements used to evaluate Amgen's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.5912 | |||
| Standard Deviation | 1.87 | |||
| Variance | 3.49 | |||
| Risk Adjusted Performance | (0.03) |
Amgen Stock Against Markets
Picking the right benchmark for Amgen stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Amgen stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Amgen is critical whether you are bullish or bearish towards Amgen Inc at a given time. Please also check how Amgen's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Amgen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
| All Next | Launch Module |
Amgen Corporate Directors
Amgen corporate directors refer to members of an Amgen board of directors. The board of directors generally takes responsibility for the Amgen's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Amgen's board members must vote for the resolution. The Amgen board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Frank Herringer | Independent Director | Profile | |
| Francois Carbonnel | Independent Director | Profile | |
| Rebecca Henderson | Independent Director | Profile | |
| Sanders Williams | Independent Director | Profile |
How to buy Amgen Stock?
Before investing in Amgen, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Amgen. To buy Amgen stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Amgen. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Amgen stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Amgen Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Amgen Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Amgen Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Amgen Stock please use our How to Invest in Amgen guide.
Already Invested in Amgen Inc?
The danger of trading Amgen Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Amgen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Amgen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Amgen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Amgen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amgen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amgen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amgen Inc Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |